The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders

Annals of Clinical Psychiatry

Volumn 24, Issue 1, 2012, Pages 56-68

  Rosenbluth, Michael ^a,b   MacQueen, Glenda ^c   McIntyre, Roger S ^b   Beaulieu, Serge ^d   Schaffer, Ayal ^b  

^a TORONTO EAST GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Bipolar disorder; Borderline personality disorder; Clinical guidelines; Major depressive disorder; Mood disorders; Personality disorders

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; FLUOXETINE; FLUPENTIXOL DECANOATE; HALOPERIDOL; LAMOTRIGINE; MOOD STABILIZER; OLANZAPINE; OMEGA 3 FATTY ACID; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; VALPROIC ACID;

ANTISOCIAL BEHAVIOR; AVOIDANT PERSONALITY DISORDER; BIPOLAR I DISORDER; CANADA; CLINICAL PRACTICE; COGNITIVE THERAPY; COMORBIDITY; CONSENSUS; COPING BEHAVIOR; DEPRESSION; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; HISTRIONIC PERSONALITY DISORDER; HUMAN; INTERPERSONAL THERAPY; LIFE STRESS; MAJOR DEPRESSION; MEDICAL SOCIETY; MOOD DISORDER; NARCISSISM; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY DISORDER; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL ENVIRONMENT; PSYCHOTHERAPY; REVIEW; SCHIZOTYPAL PERSONALITY DISORDER; SUICIDAL BEHAVIOR; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; ADVISORY COMMITTEE; BIPOLAR DISORDER; IMMUNOLOGY; METHODOLOGY; PRACTICE GUIDELINE; SUICIDAL IDEATION;

ADVISORY COMMITTEES; BIPOLAR DISORDER; CANADA; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; HUMANS; MOOD DISORDERS; PERSONALITY DISORDERS; PSYCHOTHERAPY; SUICIDAL IDEATION;

EID: 84861425951     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Krueger RF. Continuity of axes I and II: toward a unified model of personality, personality disorders, and clinical disorders. J Pers Disord. 2005;19:233-261. (Pubitemid 40934707)
2. Goodman M, New AS, Triebwasser J, et al. Phenotype, endophenotype, and genotype comparisons between borderline personality disorder and major depressive disorder. J Pers Disord. 2010;24:38-59.
3. Akiskal HS, Hirschfeld RM, Yerevanian BI. The relationship of personality to affective disorders. Arch Gen Psychiatry. 1983;40:801-810.
4. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462-1470. (Pubitemid 30318269)
5. Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry. 2002;159:359-371. (Pubitemid 34184728)
6. Kwon JS, Kim YM, Chang CG, et al. Three-year follow-up of women with the sole diagnosis of depressive personality disorder: subsequent development of dysthymia and major depression. Am J Psychiatry. 2000;157:1966-1972.
7. Harkness KL, Bagby RM, Joffe RT, et al. Major depression, chronic minor depression, and the five-factor model of personality. Eur J Pers. 2002;16:271-281. (Pubitemid 37239641)
8. Russell JM, Kornstein SG, Shea MT, et al. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. J Clin Psychiatry. 2003;64:554-561. (Pubitemid 36618285)
9. Markowitz JC, Moran ME, Kocsis JH, et al. Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients. J Affect Disord. 1992;24:63-71.
10. Miller IW, Norman WH, Dow MG. Psychosocial characteristics of "double depression." Am J Psychiatry. 1986;143:1042-1044.
11. Sanderson WC, Wetzler S, Beck AT, et al. Prevalence of personality disorders in patients with major depression and dysthymia. Psychiatry Res. 1992;42:93-99.
12. Zaretsky A, Rosenbluth M, Silver D. Clinical strategies for efficient treatment of major depressive disorder complicated by personality disorder. In: Rosenbluth M, Kennedy SH, Bagby RM, eds. Depression and personality: conceptual and clinical challenges. Arlington, VA: American Psychiatric Publishing; 2005:121-157.
13. Howland RH, Thase ME. Refractory and chronic depression: the role of axis II disorders in assessment and treatment. In: Rosenbluth M, Kennedy SH, Bagby RM, eds. Depression and personality: conceptual and clinical challenges. Arlington, VA: American Psychiatric Publishing; 2005:157-187.
14. Klein DN, Schatzberg AF, McCullough JP, et al. Early- versus late-onset dysthymic disorder: comparison in out-patients with superimposed major depressive episodes. J Affect Disord. 1999;52:187-196. (Pubitemid 29232048)
15. Klein DN, Schatzberg AF, McCullough JP, et al. Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord. 1999;55:149-157.
16. Fava M, Alpert JE, Borus JS, et al. Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry. 1996;153:1308-1312. (Pubitemid 26334204)
17. Pepper CM, Klein DN, Anderson RL, et al. DSM-III-R axis II comorbidity in dysthymia and major depression. Am J Psychiatry. 1995;152:239-247.
18. Ilardi S, Craighead WE. Personality pathology and response to somatic treatments for major depression: a critical review. Depression. 1995;2:200-217.
19. Brieger P, Ehrt U, Marneros A. Frequency of comorbid personality disorders in bipolar and unipolar affective disorders. Compr Psychiatry. 2003;44:28-34. (Pubitemid 36056771)
20. Smith DJ, Muir WJ, Blackwood DH. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression. J Affect Disord. 2005;87:17-23. (Pubitemid 40828199)
21. John H, Sharma V. Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences. World J Biol Psychiatry. 2009;10:612-615.
22. Ruggero CJ, Zimmerman M, Chelminski I, et al. Borderline personality disorder and the misdiagnosis of bipolar disorder. J Psychiatr Res. 2010;44:405-408.
23. Gunderson JG, Weinberg I, Daversa MT, et al. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. Am J Psychiatry. 2006;163:1173-1178. (Pubitemid 44464444)
24. Paris J. Effectiveness of different psychotherapy approaches in the treatment of borderline personality disorder. Curr Psychiatry Rep. 2010;12:56-60.
25. Boyce P, Mason C. An overview of depression-prone personality traits and the role of interpersonal sensitivity. Aust N Z J Psychiatry. 1996;30:90-103. (Pubitemid 26147513)
26. Skodol AE, Stout RL, McGlashan TH, et al. Co-occurrence of mood and personality disorders: a report from the Collaborative Longitudinal Personality Disorders Study (CLPS). Depress Anxiety. 1999;10:175-182. (Pubitemid 30038847)
27. Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry. 1999;40:245-252. (Pubitemid 29319237)
28. Zanarini MC, Frankenburg FR, Dubo ED, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998;155:1733-1739. (Pubitemid 28547499)
29. Craighead WE, Sheets ES, Wilcoxon-Craighead L, et al. Recurrence of MDD: a prospective study of personality pathology and cognitive distortions. Personality Disorders: Theory, Research, and Treatment. 2010;2:83-97.
30. Shea MT, Yen S. Personality traits/disorders: a summary of conceptual and empirical findings. In: Rosenbluth M, Kennedy SH, Bagby RM, eds. Depression and personality: conceptual and clinical challenges. Arlington, VA: American Psychiatric Publishing; 2005: 157-187.
31. Klein DN, Kotov R, Bufferd SJ. Personality and depression: explanatory models and review of the evidence. Annu Rev Clin Psychol. 2011;7:269-295.
32. Mullen LS, Blanco C, Vaughan SC, et al. Defense mechanisms and personality in depression. Depress Anxiety. 1999;10:168-174. (Pubitemid 30038846)
33. Hirschfeld RM, Russell JM, Delgado PL, et al. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J Clin Psychiatry. 1998;59:669-675. (Pubitemid 29068312)
34. Fava M, Farabaugh AH, Sickinger AH, et al. Personality disorders and depression. Psychol Med. 2002;32:1049-1057.
35. Morey LC, Shea MT, Markowitz JC, et al. State effects of major depression on the assessment of personality and personality disorder. Am J Psychiatry. 2010;167:528-535.
36. Michels R. Personality disorders in the depressed: seeing clearly through blue lenses. Am J Psychiatry. 2010;167:487-488.
37. Mulder RT, Joyce PR, Frampton CM. Personality disorders improve in patients treated for major depression. Acta Psychiatr Scand. 2010;122:219-225.
38. Clark LA. Assessment and diagnosis of personality disorder: perennial issues and an emerging reconceptualization. Annu Rev Psychol. 2007;58:227-257.
39. Shedler J, Beck A, Fonagy P, et al. Personality disorders in DSM-5. Am J Psychiatry. 2010;167:1026-1028.
40. Skodol AE. Revision of the personality disorder model for DSM-5. Am J Psychiatry. 2011;168:97.
41. Shedler J, Beck AT, Fonagy P, et al. Response to Skodol letter. Am J Psychiatry. 2011;168:97-98.
42. Shea MT, Pilkonis PA, Beckham E, et al. Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 1990;147:711-718. (Pubitemid 20188508)
43. Shea MT, Widiger TA, Klein MH. Comorbidity of personality disorders and depression: implications for treatment. J Consult Clin Psychol. 1992;60:857-868.
44. Bschor T, Canata B, Müller-Oerlinghausen B, et al. Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression. J Affect Disord. 2001;64:261-265. (Pubitemid 32324219)
45. Rothschild L, Zimmerman M. Interface between personality and depression. In: Alpert JE, Fava M, eds. Handbook of chronic depression. New York, NY: Marcel Dekker; 2004:19-48.
46. Frank E, Kupfer DJ. Axis II personality disorders and personality features in treatment-resistant and refractory depression. In: Roose SP, Glassman AH, eds. Treatment strategies for refractory depression. Washington, DC: American Psychiatric Press; 1990:207-221.
47. Bagby RM, Ryder AG, Cristi C. Psychosocial and clinical predictors of response to pharmacotherapy for depression. J Psychiatry Neurosci. 2002;27:250-257. (Pubitemid 34988905)
48. Petersen T, Hughes M, Papakostas GI, et al. Treatment-resistant depression and Axis II comorbidity. Psychother Psychosom. 2002;71:269-274. (Pubitemid 35007651)
49. Hayden EP, Klein DN. Outcome of dysthymic disorder at 5-year follow-up: the effect of familial psychopathology, early adversity, personality, comorbidity, and chronic stress. Am J Psychiatry. 2001;158:1864-1870. (Pubitemid 33054780)
50. Grilo CM, Stout RL, Markowitz JC, et al. Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study. J Clin Psychiatry. 2010;71:1629-1635.
51. Skodol AE, Grilo CM, Keyes KM, et al. Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry. 2011;168:257-264.
52. Weissman MM. Can epidemiology translate into understanding major depression with borderline personality disorder? Am J Psychiatry. 2011;168:231-233.
53. Gabbard GO, Simonsen E. The impact of personality and personality disorders on the treatment of depression. Personality and Mental Health. 2007;1:161-175.
54. Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry. 2006;188:13-20. (Pubitemid 43021921)
55. Mulder R. Personality disorder and outcome in depression. Br J Psychiatry. 2006;189:186-187.
56. Mulder RT, Joyce PR, Frampton CM, et al. Six months of treatment for depression: outcome and predictors of the course of illness. Am J Psychiatry. 2006;163:95-100. (Pubitemid 43050109)
57. Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry. 2002;159:359-371. (Pubitemid 34184728)
58. Kool S, Dekker J, Duijsens IJ, et al. Changes in personality pathology after pharmacotherapy and combined therapy for depressed patients. J Pers Disord. 2003;17:60-72. (Pubitemid 36343240)
59. Joyce PR, Mulder RT, Cloninger CR. Temperament predicts clomipramine and desipramine response in major depression. J Affect Disord. 1994;30:35-46.
60. Nelson E, Cloninger CR. Exploring the TPQ as a possible predictor of antidepressant response to nefazodone in a large multi-site study. J Affect Disord. 1997;44:197-200. (Pubitemid 27297858)
61. Tome MB, Cloninger CR, Watson JP, et al. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. J Affect Disord. 1997;44:101-109. (Pubitemid 27297848)
62. Sato T, Hirano S, Narita T, et al. Temperament and character inventory dimensions as a predictor of response to antidepressant treatment in major depression. J Affect Disord. 1999;56:153-161. (Pubitemid 30058217)
63. Marijnissen G, Tuinier S, Sijben AE, et al. The temperament and character inventory in major depression. J Affect Disord. 2002;70:219-223. (Pubitemid 34765565)
64. Newman JR, Ewing SE, McColl RD, et al. Tridimensional personality questionnaire and treatment response in major depressive disorder: a negative study. J Affect Disord. 2000;57:241-247. (Pubitemid 30119979)
65. Petersen T, Papakostas GI, Bottonari K, et al. NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Psychiatry Res. 2002;109:9-16. (Pubitemid 34159305)
66. Tang TZ, DeRubeis RJ, Hollon SD, et al. Personality change during depression treatment: a placebo-controlled trial. Arch Gen Psychiatry. 2009;66:1322-1330.
67. Kennedy SH, Farvolden P, Cohen NL, et al. The impact of personality on pharmacological treatment of depression. In: Rosenbluth M, Kennedy SH, Bagby RM, eds. Depression and personality: conceptual and clinical challenges. Arlington, VA: American Psychiatric Publishing; 2005:97-121.
68. Reich J. Diagnostic stability of personality disorders. Am J Psychiatry. 2004;161:926-927.
69. McGlashan TH, Grilo CM, Sanislow CA, et al. Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders. Am J Psychiatry. 2005;162:883-889. (Pubitemid 40676200)
70. Bagby RM, Quilty LC. The impact of personality and personality disorders on the treatment of depression: a brief commentary on Gabbard and Simonsen. Personality and Mental Health. 2007;1:176-178.
71. Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry. 2001;158:295-302. (Pubitemid 32116528)
72. Lewinsohn PM, Rohde P, Seeley JR, et al. Axis II psychopathology as a function of Axis I disorders in childhood and adolescence. J Am Acad Child Adolesc Psychiatry. 1997;36:1752-1759. (Pubitemid 27512330)
73. Parker G, Roy K, Hadzi-Pavlovic D, et al. Distinguishing early and late onset non-melancholic unipolar depression. J Affect Disord. 2003;74:131-138. (Pubitemid 36428694)
74. Sirey JA, Bruce ML, Alexopoulos GS, et al. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001;52:1615-1620. (Pubitemid 33104454)
75. Ekselius L, Bengtsson F, von Knorring L. Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality. Int Clin Psychopharmacol. 2000;15:273-278. (Pubitemid 30660962)
76. Bock C, Bukh JD, Vinberg M, et al. The influence of comorbid personality disorder and neuroticism on treatment outcome in first episode depression. Psychopathology. 2010;43:197-204.
77. Thase ME, Kupfer DJ. Characteristics of treatment-resistant depression. In: Zohar J, Belmaker RH, eds. Treating resistant depression. New York, NY: PMA Publishing Corp.; 1987:23-45.
78. Thase ME, Trivedi MH, Rush AJ. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology. 1995;12:185-219.
79. Bieling PJ, MacQueen GM, Marriot MJ, et al. Longitudinal outcome in patients with bipolar disorder assessed by life-charting is influenced by DSM-IV personality disorder symptoms. Bipolar Disord. 2003;5:14-21. (Pubitemid 36621628)
80. Dutta R, Boydell J, Kennedy N, et al. Suicide and other causes of mortality in bipolar disorder: a longitudinal study. Psychol Med. 2007;37:839-847. (Pubitemid 46746328)
81. Leverich GS, Altshuler LL, Frye MA, et al. Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry. 2003;64:506-515. (Pubitemid 36618278)
82. Garno JL, Goldberg JF, Ramirez PM, et al. Bipolar disorder with comorbid cluster B personality disorder features: impact on suicidality. J Clin Psychiatry. 2005;66:339-345. (Pubitemid 40476757)
83. Binks CA, Fenton M, McCarthy L, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2006: CD005652.
84. Hadjipavlou G, Ogrodniczuk JS. Promising psychotherapies for personality disorders. Can J Psychiatry. 2010;55:202-210.
85. Zanarini MC. Psychotherapy of borderline personality disorder. Acta Psychiatr Scand. 2009;120:373-377.
86. Zanarini MC. Reasons for change in borderline personality disorder (and other axis II disorders). Psychiatr Clin North Am. 2008;31:505-515. (Pubitemid 351970129)
87. Blum N, St John D, Pfohl B, et al. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry. 2008;165:468-478. (Pubitemid 351694290)
88. Black DW, Blum N, Pfohl B, et al. The STEPPS group treatment program for outpatients with borderline personality disorder. J Contemp Psychother. 2004;34:193-210. (Pubitemid 40941097)
89. Silk KR. Augmenting psychotherapy for borderline personality disorder: the STEPPS program. Am J Psychiatry. 2008;165:413-415. (Pubitemid 351694280)
90. National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Clinical Excellence. Borderline personality disorder: treatment and management. http://www.nice.org.uk/nicemedia/pdf/ CG78FullGuideline.pdf. Published 2009. Accessed January 10, 2012.
91. Gibbon S, Duggan C, Stoffers J, et al. Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2010:CD007668.
92. Stoffers J, Völlm BA, Rücker G, et al. Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev. 2010:CD005653.
93. Lieb K, Völlm B, Rücker G, et al. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry. 2010;196:4-12.
94. Ingenhoven T, Lafay P, Rinne T, et al. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry. 2010;71:14-25.
95. Khalifa N, Duggan C, Stoffers J, et al. Pharmacological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2010:CD007667.
96. Bellino S, Rinaldi C, Bogetto F. Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapy. Can J Psychiatry. 2010; 55:74-81.
97. Bellino S, Zizza M, Rinaldi C, et al. Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy. Can J Psychiatry. 2007;52:718-725. (Pubitemid 350085585)
98. Preston GA, Marchant BK, Reimherr FW, et al. Borderline personality disorder in patients with bipolar disorder and response to lamotrigine. J Affect Disord. 2004;79:297-303. (Pubitemid 38340560)
99. Swartz HA, Pilkonis PA, Frank E, et al. Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy. Bipolar Disord. 2005;7:192-197. (Pubitemid 40439480)
100. Gabbard GO. Do all roads lead to Rome? New findings on borderline personality disorder. Am J Psychiatry. 2007;164:853-855. (Pubitemid 46972897)